Mar 05, 2020
Allergan Receives FDA Approval for DURYSTA(TM) (bimatoprost implant) the First and Only Intracameral Biodegradable Sustained-Release Implant to lower Intraocular Pressure in Open-Angle Glaucoma or Ocular Hypertension Patients
Feb 25, 2020
Allergan to Present New Data for Investigational Bimatoprost Sustained-Release at American Glaucoma Society Annual Meeting
May 03, 2019
Allergan to Present Two Podium Presentations on Bimatoprost Sustained-Release (SR) at The American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting
Apr 25, 2019
Allergan to Showcase Continued Eye Care Innovation with New Data at The Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
Jun 27, 2018
Advancing Neurostimulation Therapies for Optical Deficiencies Impacting Healthcare Industry in a Billion Dollar Way
Jun 13, 2018
Allergan Announces Positive Topline Phase 3 Clinical Data for Bimatoprost SR (Sustained-Release) Implant for IOP Lowering in Patients with Open-Angle Glaucoma or Ocular Hypertension
May 01, 2018
Safer Results with Drug-Free Zoria® Lash Intensifying Serum from OCuSOFT®
Apr 26, 2018
Allergan Presents Data at the Annual Meeting of the Association of Research in Vision and Ophthalmology (ARVO) Annual Meeting in Honolulu
Nov 08, 2017
FDA understates percentage of foreign-made medication sold in U.S.
Nov 08, 2017
Allergan to Present Dynamic Eye Care Data at American Academy of Ophthalmology Meeting in New Orleans
Sep 12, 2017
Allergan Launches New Brilliant Distinctions® Patient Loyalty Program